Tocilizumab (RoActemra) and Tranexamic Acid (Cyklokapron) Used as Adjuncts to Chronic Subdural Hematoma Surgery
Phase of Trial: Phase I/II
Latest Information Update: 17 Jan 2020
Price : $35 *
At a glance
- Drugs Tocilizumab (Primary) ; Tranexamic acid (Primary)
- Indications Subdural haematoma
- Focus Therapeutic Use
- 08 Sep 2019 Planned End Date changed from 1 May 2020 to 30 Nov 2020.
- 08 Sep 2019 Planned primary completion date changed from 1 Nov 2019 to 31 May 2020.
- 23 Apr 2018 Status changed from not yet recruiting to recruiting.